Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy

✍ Scribed by Paul J. Hesketh; Matti Aapro; James C. Street; Alexandra D. Carides

• Publisher: Springer-Verlag
• Year: 2009
• Tongue: English
• Weight: 150 KB
• Volume: 18
• Category: Article
• ISSN: 0941-4355
• DOI: 10.1007/s00520-009-0737-9